Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs
Authors:
- 15 September 2011
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 19 (8) , 852-859
Abstract
Adeno-associated viral vector 9 (AAV9) has recently been shown to penetrate the blood–brain barrier via intravascular administration, making it a good candidate for diffuse gene delivery. However, the potential side effects of systemic delivery are unknown. Intrathecal viral vector administration may be more invasive than intravenous injections, but it requires far less vector and it can be performed on an outpatient basis, making it an ideal route of delivery for clinical translation. A total of 12 domestic farm pigs (<20 kg) underwent a single-level lumbar laminectomy with intrathecal catheter placement for AAV9 delivery. Animals were perfused and the tissue was harvested 30 days after treatment. Gene expression was assessed by anti-green fluorescent protein immunohistochemistry. Although a single lumbar injection resulted in gene expression limited to the lumbar segment of the spinal cord, three consecutive boluses via a temporary catheter resulted in diffuse transduction of motor neurons (MNs) throughout the cervical, thoracic and lumbar spinal cords. We now present the first successful robust transduction of MNs in the spinal cord of a large animal via intrathecal gene delivery using a self-complementary AAV9. These promising results can be translated to many MN diseases requiring diffuse gene delivery.Keywords
This publication has 46 references indexed in Scilit:
- Comparison of Adeno-Associated Viral Vector Serotypes for Spinal Cord and Motor Neuron Gene DeliveryHuman Gene Therapy, 2011
- Viral vector-mediated gene transfer for CNS diseaseExpert Opinion on Biological Therapy, 2010
- Efficient transduction of non-human primate motor neurons after intramuscular delivery of recombinant AAV serotype 6Gene Therapy, 2009
- Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALSNeurobiology of Disease, 2009
- Efficient Retrograde Neuronal Transduction Utilizing Self-complementary AAV1Molecular Therapy, 2008
- Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALSBrain Research, 2007
- Effect of Altering Titer, Serotype, and Promoter in Recombinant Adenoassociate Virus Gene Therapy Expression of Spinal Cord Neurons and AstrocytesSpine, 2004
- Recombinant AAV Viral Vectors Pseudotyped with Viral Capsids from Serotypes 1, 2, and 5 Display Differential Efficiency and Cell Tropism after Delivery to Different Regions of the Central Nervous SystemMolecular Therapy, 2004
- Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector deliveryNeurobiology of Disease, 2003
- Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS ModelScience, 2003